Table 4.
Variable | N | Death No. | 5-Year OS Rate (95% CI) | Hazard Ratio (95% CI) | P Value⁎ |
---|---|---|---|---|---|
All primary patients | 24 | 14 | 44.7% (23-64.4%) | ||
Age at diagnosis | 1.04 (0.99-1.09) | .14 | |||
FIGO stage | |||||
I | 14 | 8 | 51.3% (21.4-74.9%) | Ref. level | .61 |
II/III/IV | 10 | 6 | 33.3% (6.3-64.6%) | 1.32 (0.45-3.82) | |
Clade | |||||
Clade 1 | 9 | 7 | 22.2% (3.4-51.3%) | Ref. level | .04 |
Clade 2 | 15 | 7 | 57.8% (24.8-80.5%) | 0.33 (0.11-0.98) | |
Size | |||||
≤ 10 cm | 13 | 8 | 48.5% (17.9-73.7%) | Ref. level | .59 |
> 10 cm | 11 | 6 | 40% (12.3-67%) | 1.34 (0.46-3.89) | |
Mitotic index (five missing) | |||||
≤ 20 | 13 | 5 | 59.3% (27.5-81%) | Ref. level | .09 |
> 20 | 6 | 5 | 40% (5.2-75.3%) | 2.85 (0.82-9.89) |
P values were obtained by using Wald test based on Cox proportional hazards model for “age at diagnosis” and the log-rank test for the other variables.